Subscribe To
aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 2023 (GLOBE NEWSWIRE) — ...
November 3, 2023, 8:30 pm
aligos therapeutics announces award of an $8.5 million niaid contract to advance development of best-in-class pan-coronavirus protease inhibitor, alg-097558
– NIAID contract will support conducting nonclinical and clinical studies to advance ALG-097558 into future Phase 2/3 studies – This is the second...
October 3, 2023, 11:30 am
aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) — aligos Therapeutics, Inc. (Nasdaq: ALGS...
June 7, 2023, 11:30 am
aligos therapeutics to present data on its liver disease programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- aligos Therapeutics, Inc. (Nasdaq: ALGS)...
June 7, 2023, 7:30 am
aligos therapeutics to present at the jefferies 2023 healthcare conference
SOUTH SAN FRANCISCO, Calif., May 24, 2023 (GLOBE NEWSWIRE) — aligos Therapeutics, Inc. (Nasdaq: ALGS)...
May 24, 2023, 9:26 pm
aligos therapeutics to present at the jefferies 2023 healthcare conference
SOUTH SAN FRANCISCO, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- aligos Therapeutics, Inc. (Nasdaq: ALGS),...
May 24, 2023, 5:26 pm
aligos therapeutics announces research collaboration and development agreement with xiamen amoytop biotech co. ltd. for use of aligos’ oligonucleotide platform for the treatment of liver diseases
SOUTH SAN FRANCISCO, Calif., May 12, 2023 (GLOBE NEWSWIRE) — aligos Therapeutics, Inc. (Nasdaq: ALGS,...
May 12, 2023, 9:05 pm
aligos therapeutics, inc. (algs) reports q1 loss, lags revenue estimates
aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $0.53 per share versus the Zacks Con...
May 4, 2023, 8:30 pm
aligos therapeutics to present data from chronic hepatitis b and hepatocellular carcinoma programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- aligos Therapeutics, Inc. (Nasdaq: ALGS...
April 11, 2023, 6:50 pm
aligos therapeutics, inc. (algs) reports q4 loss, tops revenue estimates
aligos Therapeutics, Inc. (ALGS) delivered earnings and revenue surprises of -4.08% and 26.32%, respect...
March 9, 2023, 7:49 pm
aligos therapeutics to present at the svb securities global biopharma conference
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) — aligos Therapeutics, Inc. (Nasdaq: ALGS...
February 10, 2023, 12:00 pm